Orion Infusion Limited reported earnings results for the second quarter and six months ended December 31, 2022. For the second quarter, the company reported sales was BDT 199.05 million compared to BDT 190.87 million a year ago. Net income was BDT 8.13 million compared to BDT 5.39 million a year ago. Basic earnings per share from continuing operations was BDT 0.4 compared to BDT 0.26 a year ago.
For the six months, sales was BDT 423.99 million compared to BDT 430.75 million a year ago. Net income was BDT 20.95 million compared to BDT 19.99 million a year ago. Basic earnings per share from continuing operations was BDT 1.03 compared to BDT 0.98 a year ago.